Founded in 2010, ICE Bioscience is dedicated to building a target-driven drug discovery biology platform. As a pioneer in the innovative CRO+ model, ICE Bioscience focuses on addressing the challenges of biology and pharmacology from Target Identification to Pre-Clinical Candidate Selection. Our interdisciplinary team, which integrates expertise in biology, DMPK and translational medicine, leverages deep insights into disease biology and drug discovery processes to create a fully integrated platform. This platform provides comprehensive solutions specifically tailored to the needs of biopharmaceutical companies, biotechnology firms, and research institutions. ICE Bioscience aims to build strong relationships and deliver high-quality services globally. These efforts enhance our ability to support clients worldwide in their drug discovery endeavors, further establishing ICE Bioscience as a trusted partner in the pharmaceutical industry.
LEARN MORE
Over 15000 square
meters of laboratory
Over 1500 research
projects
Serving over 1000 technology
enterprises
Investing over 150 million yuan
in research and development
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
